TITRATION OF LIPID LOWERING THERAPY AFTER LIPOPROTEIN (A) MEASUREMENT IN BLACK VS. WHITE INDIVIDUALS IN THE AHA LP(A) COHORT

被引:0
|
作者
Bhatla, Anjali [1 ]
Ding, Jie [1 ]
Eidensohn, Yehuda [1 ]
Martin, Seth Shay [1 ]
Marvel, Francoise [1 ]
机构
[1] Johns Hopkins Univ Hosp, Baltimore, MD USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1433-219
引用
收藏
页码:1960 / 1960
页数:1
相关论文
共 5 条
  • [1] Effectiveness of low-density lipoprotein cholesterol reduction with lipid lowering therapy for secondary prevention amongst older individuals: a nationwide cohort study
    Andersson, Niklas W.
    Corn, Giulia
    Dohlmann, Tine L.
    Melbye, Mads
    Wohlfahrt, Jan
    Lund, Marie
    AGE AND AGEING, 2024, 53 (01)
  • [2] Trends in low-density lipoprotein cholesterol goal achievement and changes in lipid-lowering therapy after incident atherosclerotic cardiovascular disease: Danish cohort study
    Ersboll, Annette Kjaer
    Kristensen, Marie Skov
    Nybo, Mads
    Hede, Simone Moller
    Mikkelsen, Kristian Handberg
    Gislason, Gunnar
    Lytken Larsen, Mogens
    Green, Anders
    PLOS ONE, 2023, 18 (05):
  • [3] Lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment after acute coronary syndrome: a Danish population-based cohort study
    Marie Skov Kristensen
    Anders Green
    Mads Nybo
    Simone Møller Hede
    Kristian Handberg Mikkelsen
    Gunnar Gislason
    Mogens Lytken Larsen
    Annette Kjær Ersbøll
    BMC Cardiovascular Disorders, 20
  • [4] Lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment after acute coronary syndrome: a Danish population-based cohort study
    Kristensen, Marie Skov
    Green, Anders
    Nybo, Mads
    Hede, Simone Moller
    Mikkelsen, Kristian Handberg
    Gislason, Gunnar
    Larsen, Mogens Lytken
    Ersboll, Annette Kjaer
    BMC CARDIOVASCULAR DISORDERS, 2020, 20 (01)
  • [5] Real-world analyses of mortality risk after androgen deprivation therapy initiation in Black vs. White patients with prostate cancer.
    Moul, Judd W.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 84 - 84